EMEA-000026-PIP02-11

Key facts

Invented name
Torisel
Active substance
Temsirolimus
Therapeutic area
Oncology
Decision number
P/262/2011
PIP number
EMEA-000026-PIP02-11
Pharmaceutical form(s)
Concentrate and diluent for solution for infusion
Condition(s) / indication(s)
Treatment of mantle cell lymphoma
Route(s) of administration
Intravenous use
Contact for public enquiries
Pfizer Limited
United Kingdom
PIP_Enquiries@pfizer.com
+44 1304646607 
+44 1304653601
Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating